Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ZGPAT mRNA | affects expression | 21346803
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of ZGPAT mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of ZGPAT mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZGPAT mRNA | affects cotreatment|increases expression | 17942748
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ZGPAT mRNA | affects binding|decreases expression|increases activity | 19710929
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of ZGPAT mRNA | increases expression | 18175754
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of ZGPAT mRNA | affects expression | 17555576
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of ZGPAT mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZGPAT mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.24 | 11752688 14514962 15322242 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.38 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.42 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.86 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.26 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.26 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.82 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.82 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.73 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.73 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.93 | 19200415 19103187 15565566 16202921 19084267 19244106 16873071 20859285 21152245 16818667 20544844 19066611 17440819 18351453 19011961 11161223 19189212 19288272 15668708 19289846 19115204 18629630 19189210 18997820 19410462 19059307 17242785 19221464 21138602 20390343 17261762 20005174 18984771 18821012 17049068 20065188 17893378 19155303 18425577 18815881 19487384 19142967 20135344 18855134 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.87 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.09 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.09 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.88 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 16120746 18850075 18670907 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.42 | 17681005 17110522 16919318 15861022 16105132 17333356 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.42 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.11 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 16354765 15668235 8697196 12621046 15340226 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.37 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.72 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.53 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.03 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.72 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.61 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.61 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.61 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.48 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.48 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.06 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.06 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.21 | 16202921 17893378 20544844 19155303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
14.74 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.74 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
14.74 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.39 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.92 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.58 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.69 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.48 | 19176532 16221962 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.48 | 15340226 12621046 16120746 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.19 | 17440010 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 15340226 16959395 8697196 18606429 16354765 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.45 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.17 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.77 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.66 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.32 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.32 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.88 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.88 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.17 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.17 | 18625569 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.35 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.53 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.53 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.53 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.86 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.86 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.86 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.26 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.31 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.31 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.36 | 14737004 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.15 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.79 | 14580682 16827153 11731420 19196723 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.99 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.58 | 15990972 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.86 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.24 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.16 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.25 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.64 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.59 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.06 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.44 | 19196722 19200415 19189210 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.69 | 16049721 12819281 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.99 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11222880 11896295 11118676 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.23 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.23 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.71 | 15861022 16919318 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.50 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.71 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.15 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
13.09 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
13.09 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.43 | 19457130 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.92 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.34 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.34 | 17572228 16712894 8653321 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.71 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.63 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.82 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |